Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with significant unmet need. It is advancing a pipeline of internally developed programs with multiple drug candidates in clinical trials. Its lead asset, PIPE-791, is a novel, brain-penetrant, small-molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) in development for idiopathic pulmonary fibrosis (IPF), progressive multiple sclerosis (PrMS), and chronic pain. Its second drug candidate, PIPE-307, is a novel, small-molecule selective inhibitor of the muscarinic type 1 receptor (M1R), in development for depression and relapse-remitting multiple sclerosis (RRMS). The Company is also conducting preclinical and discovery-phase experiments targeting other NI&I indications where its internally discovered molecules may have therapeutic potential.
Find out what a historical investment in CONTINEUM THERAPEUTICS, INC. would be worth today using our CTNM stock calculator.
Buying CTNM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CONTINEUM THERAPEUTICS, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CTNM
What is the ticker symbol of CONTINEUM THERAPEUTICS, INC.?
The ticker symbol for CONTINEUM THERAPEUTICS, INC. is CTNM.
How much is one share of CTNM?
One share of CTNM is valued at $9.04 as of 20 November 2026.
What is the market capitalisation of CONTINEUM THERAPEUTICS, INC. CTNM?
As of 20 November 2026 CONTINEUM THERAPEUTICS, INC. has a market cap of $362.82M.
What is the 52-week high for CONTINEUM THERAPEUTICS, INC. stock?
The CONTINEUM THERAPEUTICS, INC. 52-week high stock price is $17.79.
What is the 52-week low for CONTINEUM THERAPEUTICS, INC. stock?
The CONTINEUM THERAPEUTICS, INC. 52-week low stock price is $6.73.
Can I buy CTNM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CTNM shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CTNM on Stake
Buy CTNM from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CTNM from only US$10 with fractional shares